← Retour au Screener

Sector: Santé
Open in Terminal → CBAV.MCLive chart · Key metrics · News · Smart money

Clinica Baviera

CBAV.MC Small Cap

Healthcare · Diagnostics & Research

Mis à jour: Aug 2, 2026, 22:14 UTC

59,60 €
+1.71% aujourd'hui
52W: 40,10 € – 61,80 €
52W Low: 40,10 € Position: 89.9% 52W High: 61,80 €

Price Chart

Indicateurs clés

P/E Ratio
20.77x
Cours/Bénéfice
Forward P/E
33.86x
P/E prévisionnel
P/S Ratio
3.13x
Cours/Ventes
EV/EBITDA
11.46x
Valeur d'entreprise/EBITDA
Rend. dividende
2.63%
Rendement annuel du dividende
Cap. boursière
828 M €
Capitalisation boursière
Croissance du CA
10.6%
Croissance du CA sur un an
Marge bénéficiaire
13.79%
Marge nette
ROE
41.02%
Rentabilité des capitaux propres
Beta
0.75
Sensibilité au marché
Positions vendeuses
% du flottant vendu à découvert
Volume moyen
3,406
Volume quotidien moyen

Valuation Analysis

Signal
Fair
vs. S&P 500 avg P/E (24.7x)
Analyst Consensus
None
0 analysts

About the Company

Sector: Healthcare Industry: Diagnostics & Research Country: Spain Employees: 1,274 Exchange: MCE

Clinica Baviera en bref

Clinica Baviera (CBAV.MC) is currently trading at 59,60 € with a market capitalization of 828 M €. The trailing P/E ratio stands at 20.77x, with a forward P/E of 33.86x. The 52-week range spans from 40,10 € to 61,80 €; the current price is 3.6% below the yearly high. Year-over-year revenue growth stands at +10.6%. The net profit margin stands at 13.79%.

💰 Dividende

Clinica Baviera pays an annual dividend of 1,57 € per share, representing a yield of 2.63%. The payout ratio stands at 57.23%.

Clinica Baviera : la thèse d'investissement en détail

Clinica Baviera (CBAV.MC) operates in the Healthcare — specifically Diagnostics & Research — and is headquartered in Spain. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Revenue is growing at a healthy 10.6% pace year-over-year, suggesting the business model continues to find new customers and pricing power. The combination of a 49.52% gross margin and 22.22% operating margin shows the business converts revenue into profit efficiently — a hallmark of competitive moat. Return on equity of 41.02% places management among the most capital-efficient operators in the public market — every euro of shareholder capital is working hard.

Thèse d'investissement : forces et faiblesses

Points forts
  • Rentabilité élevée des capitaux propres (41.02% ROE)
  • Rendement du dividende solide de 2.63%
  • Free cash flow positif
Points faibles

Aucun signal d'alerte significatif dans les indicateurs actuels.

Aperçu technique

MM 50 jours
57,31 €
+4% vs. cours
MM 200 jours
51,34 €
+16.09% vs. cours
Sous le plus haut 52s
−3.6%
61,80 €
Au-dessus du plus bas 52s
+48.6%
40,10 €

Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).

Profil de risque

Risque de marché (Bêta)
0.75 · Défensive
Évolue moins que le marché global
Dette/Capitaux propres
62.33 · Modéré
Dette totale / capitaux propres

The data points to relatively defensive market behavior.

Trading Data

50-Day MA: 57,31 €
200-Day MA: 51,34 €
Volume: 1,694
Avg. Volume: 3,406
Short Ratio:
P/B Ratio: 8.68x
Debt/Equity: 62.33x
Free Cash Flow: 35 M €

💵 Dividend Info

Dividend Yield
2.63%
Annual Rate
1,57 €
Payout Ratio
57.23%

More Santé stocks

Top peers in the same sector — ranked by market cap.

View full Santé sector page →

Where can I buy Clinica Baviera?

Compare top-rated brokers — low fees, trusted providers, fully regulated.

📊 Plutôt un fonds qu’une action isolée ? Comparatif d’ETF :

Live Market Data

Real-time chart, financials, earnings, analysts, insider trades, events & news

Financials

Earnings

Analyst Ratings

Insider Trades

Events Timeline

News + Sentiment

Peer Comparison

Retour en haut